2[1]Bohle A, Muller G A, Wehrmann M, et al. Pathogenesis of chronic renal failure in the primary glomerulopathies, renal vasculopathies and chronic interstitial nephritides [J]. Kidney Int, 1996, 49: 2.
3[3]Zhang D N. The Study of TCM Nourishing Kidney and Activating blood (中医补肾活血法研究) [M]. Beijing: China Medico-Pharmaceutical Science and Technology Publishing House, 1997.
4[4]Yang J, Liu Y. Delayed administration of hepatocyte growth factor reduces renal fibrosis in obstructive nephropathy [J]. Am J Physiol Renal Physiol, 2003, 284: 349-357.
5[5]Frazier K S, Paredes A, Dube P, et al. Connective tissue growth factor expression in the rat remnant kidney model andassociation with tubular epithelial cells undergoing transdifferentiation [J]. Vet Pathol, 2000, 37: 328-335.
6[6]Lan H Y. Tubular epithelial-myofibroblast transdifferentia-tion mechanisms in proximal tubule cells [J]. Curr Opin Nephrol Hypertens, 2003, 12: 25-29.
7[7]Yang J, Liu Y. Blockage of tubular epithelial to myofibroblast transition by hepatocyte growth factor prevents renal interstitial fibrosis [J]. J Am Soc Nephrol, 2002, 13: 96-107.
8[8]Jinde K, Nikolic-Paterson D J, Huang X R, et al. Tubular phenotypic change in progressive tubulointerstitial fibrosis in human glomerulonephritis [J]. Am J Kidney Dis, 2001, 38: 761-769.
9[9]Eddy A A. Molecular insights into renal interstitial fibrosis [J]. J Am Soc Nephrol, 1996, 7: 2495-2508.
10[10]Badid C, Mounier K, Costa A M, et al. A role of myofibroblast during normal tissue repair and excessive scaring: Interest of their assessment in nephropathies [J]. Histol Histopathol, 2000, 15: 269-280.
